1. What Would be the Best Schedule for Prevention of Meningococcal Disease in All Ages? The UK Experience

   • H. Findlow
   • R. Borrow

   Current Opinion 25 February 2016 Pages: 83 - 87

2. Drug Treatment of Heart Failure in Children: Focus on Recent Recommendations from the ISHLT Guidelines for the Management of Pediatric Heart Failure

   • Alexander D. Hussey
   • Robert G. Weintraub

   Leading Article 03 March 2016 Pages: 89 - 99

3. Difficult-To-Treat Juvenile Idiopathic Arthritis: Current and Future Options

   • Ilaria Pagnini
   • Federico Bertini
   • Rolando Cimaz

   Therapy in Practice 03 March 2016 Pages: 101 - 108

4. Optimizing the Use of Antibacterial Agents in the Neonatal Period

   • Joseph B. Cantey

   Therapy in Practice 09 January 2016 Pages: 109 - 122

   

5. Pharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration

   • Sindhu Sivanandan
   • Ramesh Agarwal

   Review Article 07 March 2016 Pages: 123 - 138

6. Long-Term Follow-Up on a Cohort Temporary Utilization Authorization (ATU) Survey of Patients Treated with Pheburane (Sodium Phenylbutyrate) Taste-Masked Granules

   • Yves Kibleur
   • Nathalie Guffon

   Short Communication 08 January 2016 Pages: 139 - 144

   

7. A Qualitative Study into Dependent Relationships and Voluntary Informed Consent for Research in Pediatric Oncology

   • Sara A. S. Dekking
   • Rieke van der Graaf
   • Johannes J. M. van Delden

   Original Research Article Open access 11 January 2016 Pages: 145 - 156